X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7504) 7504
Publication (1377) 1377
Book Chapter (67) 67
Book Review (66) 66
Conference Proceeding (31) 31
Dissertation (29) 29
Government Document (4) 4
Book / eBook (2) 2
Data Set (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4282) 4282
index medicus (4224) 4224
hsp90 heat-shock proteins - metabolism (3032) 3032
animals (2973) 2973
hsp90 (2951) 2951
heat shock proteins (2482) 2482
hsp90 heat-shock proteins - antagonists & inhibitors (2304) 2304
biochemistry & molecular biology (1690) 1690
proteins (1663) 1663
cancer (1528) 1528
cell line, tumor (1412) 1412
cell biology (1403) 1403
oncology (1350) 1350
mice (1339) 1339
apoptosis (1201) 1201
female (1019) 1019
expression (1006) 1006
hsp90 heat-shock proteins - genetics (969) 969
hsp90 protein (941) 941
male (879) 879
article (877) 877
lactams, macrocyclic - pharmacology (864) 864
geldanamycin (862) 862
benzoquinones - pharmacology (847) 847
antineoplastic agents - pharmacology (829) 829
protein binding (765) 765
activation (739) 739
research (700) 700
phosphorylation (695) 695
signal transduction (692) 692
analysis (688) 688
molecular chaperone (655) 655
apoptosis - drug effects (632) 632
cells (626) 626
chaperone (610) 610
gene expression (587) 587
in-vivo (581) 581
hsp90 heat-shock proteins - chemistry (579) 579
pharmacology & pharmacy (571) 571
heat-shock-protein (564) 564
molecular chaperones (563) 563
kinases (555) 555
inhibitors (538) 538
binding (529) 529
hsp70 heat-shock proteins - metabolism (529) 529
cell proliferation - drug effects (517) 517
heat-shock proteins (508) 508
cell line (507) 507
multidisciplinary sciences (506) 506
protein (499) 499
research article (494) 494
chemistry, medicinal (476) 476
hsp90 inhibitors (474) 474
inhibition (471) 471
mutation (466) 466
physiological aspects (452) 452
biology (449) 449
rats (448) 448
signal transduction - drug effects (447) 447
blotting, western (445) 445
complex (445) 445
lactams, macrocyclic (445) 445
benzoquinones (442) 442
heat shock protein 90 (442) 442
hsp90 inhibitor (440) 440
heat-shock-protein-90 (434) 434
protein folding (434) 434
in-vitro (426) 426
health aspects (408) 408
medicine (405) 405
heat shock (400) 400
cells, cultured (398) 398
genetic aspects (398) 398
enzyme inhibitors - pharmacology (384) 384
hsp70 (383) 383
dose-response relationship, drug (379) 379
tumors (377) 377
molecular chaperones - metabolism (376) 376
binding sites (372) 372
hsp90 heat-shock proteins - physiology (359) 359
science (357) 357
cell survival - drug effects (348) 348
neoplasms - drug therapy (347) 347
models, molecular (344) 344
oxidative stress (340) 340
growth (336) 336
stress (331) 331
molecular sequence data (329) 329
antineoplastic agents - therapeutic use (326) 326
identification (325) 325
biochemistry (324) 324
cell cycle (318) 318
amino acid sequence (316) 316
biophysics (316) 316
care and treatment (315) 315
structure-activity relationship (314) 314
quinones - pharmacology (313) 313
chaperones (309) 309
shock-protein 90 (307) 307
degradation (305) 305
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7475) 7475
Chinese (38) 38
Japanese (21) 21
Russian (11) 11
Korean (10) 10
French (9) 9
German (6) 6
Czech (2) 2
Hungarian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2010, Volume 60, Issue 4, pp. 222 - 243
Angiogenesis has become an attractive target for drug therapy because of its key role in tumor growth. An extensive array of compounds is currently in... 
CELL LUNG-CANCER | TYROSINE KINASE INHIBITORS | PHASE-III TRIAL | FARNESYL-PROTEIN TRANSFERASE | HYPOXIA-INDUCIBLE FACTOR | SUPPRESSES TUMOR-GROWTH | ONCOLOGY | ENDOTHELIAL-GROWTH-FACTOR | FACTOR EXPRESSION | VASCULAR-PERMEABILITY FACTOR | METASTATIC COLORECTAL-CANCER | Neoplasms - metabolism | Nucleic Acid Synthesis Inhibitors - pharmacology | Humans | Receptor Protein-Tyrosine Kinases - physiology | Antibodies, Monoclonal - therapeutic use | Receptors, Notch - antagonists & inhibitors | Protein Binding - drug effects | Angiogenesis Inhibitors - therapeutic use | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Neovascularization, Pathologic - prevention & control | Farnesyltranstransferase - antagonists & inhibitors | Thioredoxins - antagonists & inhibitors | Nucleic Acid Synthesis Inhibitors - therapeutic use | Basic Helix-Loop-Helix Transcription Factors - physiology | Antibodies, Monoclonal - pharmacology | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Angiogenesis Inhibitors - pharmacology | Receptors, Notch - physiology | Neoplasms - blood supply | Basic Helix-Loop-Helix Transcription Factors - antagonists & inhibitors | Neoplasms - drug therapy | Signal Transduction - drug effects | Cell Transformation, Neoplastic | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Intracellular Signaling Peptides and Proteins - physiology | Complications and side effects | Care and treatment | Ligands (Biochemistry) | Physiological aspects | Development and progression | Dosage and administration | Angiogenesis inhibitors | Neovascularization | Identification and classification | Growth factors | Cancer | Angiogenesis | Pharmacology | FDA approval | Drug therapy | Kinases | Tumors | hypoxia inducible factor (HIF) | kinase inhibitors | growth factors | angiogenesis inhibitors | VEGF | anti-angiogenesis
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2012, Volume 18, Issue 1, pp. 64 - 76
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2012, Volume 18, Issue 9, pp. 2502 - 2514
Purpose: The clinical use of BRAF inhibitors is being hampered by the acquisition of drug resistance. This study shows the potential therapeutic use of the... 
BREAST-CANCER | MULTIPLE-MYELOMA | APOPTOSIS | PHASE-II TRIAL | TANESPIMYCIN 17-AAG | TRASTUZUMAB | ONCOLOGY | BIM | ACQUIRED-RESISTANCE | MELANOMA-CELLS | POTENTIAL MECHANISM | Prospective Studies | Apoptosis - drug effects | Humans | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Immunoenzyme Techniques | Forkhead Transcription Factors - metabolism | Colony-Forming Units Assay | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Phthalic Acids - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Real-Time Polymerase Chain Reaction | Proto-Oncogene Proteins B-raf - metabolism | Membrane Proteins - genetics | Melanoma - pathology | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Apoptosis Regulatory Proteins - metabolism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Indoles - adverse effects | Membrane Proteins - antagonists & inhibitors | Signal Transduction - drug effects | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Cell Line, Tumor | HSP90 Heat-Shock Proteins - metabolism | Mice | Mice, Inbred BALB C | Forkhead Box Protein O3 | Azabicyclo Compounds - pharmacology | Phosphatidylinositol 3-Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - genetics | Proto-Oncogene Proteins c-akt - genetics | Proto-Oncogene Proteins c-bcl-2 - metabolism | Flow Cytometry | Bcl-2-Like Protein 11 | Apoptosis Regulatory Proteins - genetics | Membrane Proteins - metabolism | Forkhead Transcription Factors - antagonists & inhibitors | Melanoma - metabolism | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | RNA, Messenger - genetics | Proto-Oncogene Proteins - genetics | Forkhead Transcription Factors - genetics | Phosphatidylinositol 3-Kinases - genetics | Animals | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Myeloid Cell Leukemia Sequence 1 Protein | Apoptosis Regulatory Proteins - antagonists & inhibitors | Fluorescent Antibody Technique | Sulfonamides - adverse effects | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins c-bcl-2 - genetics | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Drug Resistance, Neoplasm - drug effects
Journal Article
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 422 - 14
Journal Article
Molecular Cell, ISSN 1097-2765, 01/2014, Volume 53, Issue 2, pp. 317 - 329
Journal Article